EFDID: 556634EFD: View Filing

Issuer: CoRegen, Inc. (0002012886) - D

Accession: 0002012886-25-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    CoRegen, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2022)
  • Address:
    600 E HOPKINS AVE
    STE 304

    ASPEN, CO 81611
  • Persons:
    Related Persons 10
    Steve Gorlin
    Executive Officer, Director 
    President of the Issuer
    David Lonard, PhD
    Executive Officer 
    Chief Science Officer of the Issuer
    John Thomas, Jr.
    Executive Officer 
    Chief Financial Officer and Secretary of Issuer
    Bert W. O'Malley
    Director
    Clifford C. Dasco, M.D.
    Executive Officer, Director 
    Chief Medical Officer of the Issuer
    Edward J. Benz, Jr.
    Director
    Lee Fleisher, M.D.
    Director
    Suneet Varma
    Director
    William Haseltine, PhD.
    Director
    Jonathan W. Simons
    Director
EDGAR: Offering Information
  • Accession Date:
    05/22/2025
  • First Sale Date:
    04/21/2025
  • Offering Amount:
    $62,640,000
  • Amount Sold:
    $62,640,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

Notices found in EFD

Filed:NY, TX
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
M M Dillon & Co. LLC 19878 Elena Ulansky 7654267 FL, NY, TX
M M Dillion & Co. LLC 19878 Jeff Robert Swarz 1563420 FL, NY, TX
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
CoRegen, Inc.John C. Thomas Jr.John C. Thomas Jr.Chief Financial Officer of the Issuer2025-05-22